High expression of DNA methyltransferase 3A (DNMT3A) at the lncRNA SLERCC (Specific Low Expression in RCC) promoter site will result in abnormal hypermethylation, which ultimately leads to decreased SLERCC expression in RCC. The gene discussed is LINC00113; the disease is renal cell carcinoma.